CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

期刊名
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

CRIT REV THER DRUG

ISSN / eISSN
0743-4863 / 2162-660X
目标和范围
Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.
Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.
研究方向

药学

CiteScore
5.50 查看趋势图
CiteScore 学科排名
类别 分区 排名
Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science Q2 #63/171
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q2 #127/301
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
PHARMACOLOGY & PHARMACY - SCIE Q3
H-index
69
出版国家或地区
UNITED STATES
出版商
Begell House Inc.
出版周期
Bimonthly
出版年份
1984
年文章数
17
Open Access
NO
通讯方式
BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started